SecBot SecBot

DMAA

Drugs Made In America Acquisition Corp.
Nasdaq· Blank Checks· CIK 0002028614 Traditional Finance
$10.88 +0.01 (+0.05%)
Oct 26 4:00 PM ET · prev $10.88
Next earnings
Nov 16
in 20 days
1 year
+5.4%
from $10.32 · Oct 27
30 days
0.0%
from $10.88
52-week range
$10.31–10.89
−0% from high · low Oct 28
Avg volume 20D
14.2K
Oct 23 spike 91.4K
Short interest
🔒 Subscribers only
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
5
analyzed by SecBot
SecBot read MIXED 3 reports · 90 days
Balance 0 bearish · 0 bullish · 2 mixed · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/3 ·Next Earnings date, Nov 16, 2026

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsBEARISH

    Q2 2026: 0 added (0 new), 4 trimmed or exited.

  • TrendUPTREND

    1% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
WOLVERINE ASSET MANAGEMENT LLCTRIM832,093$8.9M
TORONTO DOMINION BANKTRIM100,000$1.1M
HRT FINANCIAL LPTRIM18,483$196.0K
MORGAN STANLEYTRIM28$298.00

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Aug 10, 2026
Earnings date
DMAA Q2 2026 Earnings Scheduled — 2026-08-10
Aug 3, 2026
Earnings date
DMAA Q2 2026 Earnings Scheduled — 2026-08-03
Jul 21, 2026
Press release
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Drugs Made In America Acquisition Corp. (NASDAQ: DMAA)
NEW YORK, July 21, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has…
May 13, 2026
Earnings date
DMAA Q1 2026 Earnings Scheduled — 2026-05-13
May 11, 2026
Earnings date
DMAA Q1 2026 Earnings Scheduled — 2026-05-11

Earnings setup

Estimates
Nov 16
reports in 20 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.

SecBot reports

5 filings · 1 bullish · 0 bearish · 3 mixed · 1 neutral
All DMAA filing & press-release reports (5)